Glucotrack annual debt-to-equity ratio
2020
2021
2022
2023
2025
Glucotrack Debt-to-Equity Ratio Growth & History (GCTK)
Glucotrack's debt-to-equity ratio was 0.01 for fiscal 2025.
View full Glucotrack company overviewGlucotrack annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.01 | — | — |
| 2023 | 2023-12-31 | 0.06 | −0.10 | −61.33% |
| 2022 | 2022-12-31 | 0.16 | 0.15 | +1943.14% |
| 2021 | 2021-12-31 | 0.01 | −0.01 | −58.01% |
| 2020 | 2020-12-31 | 0.02 | — | — |
Glucotrack quarterly debt-to-equity ratio
Q2.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q1.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 0.01 | — | — |
| Q3 2025 | 2025-09-30 | 0.01 | — | — |
| Q2 2025 | 2025-06-30 | 0.01 | — | — |
| Q1 2025 | 2025-03-31 | 0.01 | −0.20 | −95.91% |
| Q1 2024 | 2024-03-31 | 0.21 | — | — |
| Q1 2022 | 2022-03-31 | 0.00 | −0.01 | −76.73% |
| Q4 2021 | 2021-12-31 | 0.01 | −0.01 | −58.01% |
| Q3 2021 | 2021-09-30 | 0.01 | −0.01 | −35.09% |
| Q2 2021 | 2021-06-30 | 0.01 | 0.00 | +24.31% |
| Q1 2021 | 2021-03-31 | 0.02 | 0.00 | +33.97% |
| Q4 2020 | 2020-12-31 | 0.02 | — | — |
| Q3 2020 | 2020-09-30 | 0.02 | — | — |
| Q2 2020 | 2020-06-30 | 0.01 | −11.26 | −99.90% |
| Q1 2020 | 2020-03-31 | 0.01 | — | — |
| Q2 2019 | 2019-06-30 | 11.27 | — | — |
Glucotrack debt-to-equity ratio trends
Over the last five fiscal years, Glucotrack's debt-to-equity ratio decreased from 0.02 to 0.01, a change of −0.01. The latest reported quarter, Q4 2025, shows 0.01.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Glucotrack source filings ↗